INCY · Incyte Corp · Executive Compensation

$116.62 +3.37 (+2.97%) At close · Oct 20

S&P 500 member Russell 1000 member Rebalance outlook locked

Market Cap

$23.30B

199.78M

Volume · Oct 20 1.34M Avg daily vol (3M) 1.64M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
William Meury	CEO	$647,260	—	$27,509,657	$2,573,998	$1,300,000	$55,037	$32,085,952
William J. Meury	Chief Executive Officer	$647,260	—	$27,509,657	$2,573,998	$1,300,000	$55,037	$32,085,952
Mohamed Issa	Executive Vice President and Head of U.S. Commercial	$690,411	$1,000,000	$7,870,118	$450,983	$533,610	$47,660	$10,592,782
Pablo J. Cagnoni	President and Global Head of Research and Development	$966,516	—	$4,952,378	$1,815,159	$1,007,027	$97,881	$8,838,961
Pablo Cagnoni	—	$966,516	—	$4,952,378	$1,815,159	$1,007,027	$97,881	$8,838,961
Hervé Hoppenot	Former President and Chief Executive Officer	$1,392,499	—	$1,971,975	$1,694,034	$1,026,072	$295,945	$6,380,525
Steven H. Stein	Executive Vice President, Chief Medical Officer and Head of Late-stage Development	$835,067	—	$3,466,675	$1,270,592	$696,054	$35,784	$6,304,172
Christiana Stamoulis	Former Executive Vice President and Chief Financial Officer	$520,839	—	$3,136,468	$1,149,588	—	$129,655	$4,936,550
Thomas Tray	Vice President, Chief Accounting Officer and Principal Financial Officer	$358,189	—	$305,897	$154,623	$149,423	$22,236	$990,368

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Hervé Hoppenot	Former President and Chief Executive Officer	$1,344,707	—	$10,543,489	$3,315,223	$2,202,829	$53,298	$17,459,546
Pablo Cagnoni	—	$933,344	—	$4,463,962	$1,404,291	$1,042,470	$60,232	$7,904,299
Pablo J. Cagnoni	President and Global Head of Research and Development	$933,344	—	$4,463,962	$1,404,291	$1,042,470	$60,232	$7,904,299
Steven H. Stein	Executive Vice President, Chief Medical Officer and Head of Late-stage Development	$806,406	—	$3,124,735	$1,295,829	$720,553	$32,305	$5,979,828
Christiana Stamoulis	Former Executive Vice President and Chief Financial Officer	$712,242	—	$2,827,129	$1,172,420	$636,414	$49,552	$5,397,757

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Hervé Hoppenot	Former President and Chief Executive Officer	$1,291,929	—	$9,334,654	$4,425,053	$1,554,703	$53,187	$16,659,526
Pablo Cagnoni	—	$517,808	$737,362	$14,089,823	$450,377	$735,750	$39,183	$16,570,303
Pablo J. Cagnoni	President and Global Head of Research and Development	$517,808	$737,362	$14,089,823	$450,377	$735,750	$39,183	$16,570,303
Steven H. Stein	Executive Vice President, Chief Medical Officer and Head of Late-stage Development	$775,580	—	$2,925,757	$1,386,951	$508,549	$31,256	$5,628,093
Christiana Stamoulis	Former Executive Vice President and Chief Financial Officer	$684,288	—	$2,647,095	$1,254,863	$449,166	$49,073	$5,084,485

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Hervé Hoppenot	President and Chief Executive Officer	$1,094,731	—	$8,317,223	$5,515,024	$1,403,468	$47,746	$16,378,192
Christiana Stamoulis	Executive Vice President and Chief Financial Officer	$585,468	—	$1,743,359	$1,421,498	$375,321	$28,604	$4,154,250
Barry Flannelly	Executive Vice President and General Manager—NA	$480,542	—	$2,342,694	$940,557	$308,057	$45,034	$4,116,884
Steven H. Stein	Executive Vice President and Chief Medical Officer	$576,321	—	$1,418,393	$940,557	$369,457	$22,022	$3,326,750
Vijay Iyengar	Executive Vice President, Global Strategy and Corporate Development	$552,278	—	$1,418,393	$940,557	$353,299	$40,323	$3,304,850

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Hervé Hoppenot	President and Chief Executive Officer	$1,044,376	—	$6,740,953	$5,937,070	$1,382,183	$46,656	$15,151,238
Steven H. Stein	Executive Vice President and Chief Medical Officer	$549,812	—	$4,868,505	$1,235,249	$363,825	$24,093	$7,041,484
Wenqing Yao	Executive Vice President, Head of Discovery Chemistry	$485,405	—	$4,868,505	$1,235,249	$321,206	$41,195	$6,951,560
Barry Flannelly	Executive Vice President and General Manager—NA	$458,438	—	$1,149,505	$3,490,293	$303,361	$41,345	$5,442,942
Christiana Stamoulis	Executive Vice President and Chief Financial Officer	$497,096	$280,000	$824,960	$2,474,685	$369,600	$49,327	$4,495,668

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Hervé Hoppenot	President and Chief Executive Officer	$995,575	—	$1,733,822	$5,564,508	$807,769	$212,515	$9,314,189
Steven H. Stein	Executive Vice President and Chief Medical Officer	$522,123	—	$3,733,824	$2,119,070	$212,625	$23,874	$6,611,516
Wenqing Yao	Executive Vice President, Head of Discovery Chemistry	$462,723	—	$3,733,824	$2,119,070	$187,718	$36,716	$6,540,051

Fiscal 2017

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Hervé Hoppenot	President and Chief Executive Officer	$966,505	—	$1,755,563	$11,677,844	$1,476,505	$210,614	$16,087,031
Steven H. Stein	Executive Vice President and Chief Medical Officer	$473,070	$100,000	$451,372	$2,688,504	$362,188	$24,121	$4,099,255
Wenqing Yao	Executive Vice President, Head of Discovery Chemistry	$448,798	—	$451,372	$2,688,504	$343,125	$41,374	$3,973,173

Executive changes

Person	Role	Change	Effective	Filed
Susanne Schaffert	member of the Company's Board	Resigned	2026-04-15	2026-03-30
Mohamed Issa	Executive Vice President and Head of U.S. Commercial	Appointed	2026-03-25	2026-03-26
Steven H. Stein	Executive Vice President, Chief Medical Officer and Head of Late-stage Development	Appointed	2026-03-25	2026-03-26
Pablo J. Cagnoni	President, Incyte and Global Head of Research and Development	Appointed	2026-03-25	2026-03-26
Hervé Hoppenot	Board of Directors	Retired	2025-12-10	2025-12-12
Thomas Tray	principal financial officer	Appointed	2025-09-16	2025-10-03
Christiana Stamoulis	Executive Vice President and Chief Financial Officer	Resigned	2025-09-16	2025-08-07
William J. Meury	President and Chief Executive Officer	Appointed	2025-06-26	2025-06-27
William J. Meury	Board	Appointed	2025-06-26	2025-06-27
Julian C. Baker	Chairman of the Board	Appointed	2025-06-26	2025-06-27
Hervé Hoppenot	President and Chief Executive Officer	Retired	2025-06-26	2025-06-27
Barry P. Flannelly	Executive Vice President, General Manager, North America	Retired	2025-01-06	2025-01-10
Maria E. Pasquale	Executive Vice President, General Counsel and Corporate Secretary	Retired	2023-11-01	2023-09-12
Susanne Schaffert	Director	Appointed	2023-06-14	2023-06-15
Katherine A. High	Director	Appointed	2023-06-14	2023-06-15
Hervé Hoppenot	Director	Appointed	2023-06-14	2023-06-15
Edmund P. Harrigan	Director	Appointed	2023-06-14	2023-06-15
Jacqualyn A. Fouse	Director	Appointed	2023-06-14	2023-06-15
Otis W. Brawley	Director	Appointed	2023-06-14	2023-06-15
Paul J. Clancy	Director	Appointed	2023-06-14	2023-06-15
Jean-Jacques Bienaimé	Director	Appointed	2023-06-14	2023-06-15
Julian C. Baker	Director	Appointed	2023-06-14	2023-06-15
Susanne Schaffert, Ph.D.	member of the Board of Directors	Appointed	2022-10-01	2022-10-04

Leadership

William J. Meury CEO, Board Member
Julian C. Baker Chairman, Board Member
Thomas Tray Chief Accounting Officer
Edmund P. Harrigan Board Member
Hervé Hoppenot Board Member
Jacqualyn A. Fouse Board Member
Jean-Jacques Bienaimé Board Member
Katherine A. High Board Member
Katherine A. High, M.D. Board Member
Otis W. Brawley Board Member
Otis W. Brawley, M.D. Board Member
Paul J. Clancy Board Member
Susanne Schaffert Board Member
Susanne Schaffert, Ph.D. Board Member
Wendy L. Dixon Board Member

Key facts CIK 879169 CUSIP 45337C102 13F (30d) 157 filings 148 filers Visit website Investor relations